Parkside Financial Bank & Trust’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-52
Closed -$5.12K 2717
2025
Q2
$5.12K Sell
52
-12
-19% -$1.14K ﹤0.01% 1700
2025
Q1
$5.93K Buy
64
+27
+73% +$2.49K ﹤0.01% 1597
2024
Q4
$3.36K Buy
37
+5
+16% +$459 ﹤0.01% 1531
2024
Q3
$3.09K Hold
32
﹤0.01% 1526
2024
Q2
$2.94K Sell
32
-359
-92% -$33.3K ﹤0.01% 1483
2024
Q1
$36K Buy
391
+60
+18% +$5.62K 0.01% 857
2023
Q4
$31.5K Buy
331
+16
+5% +$1.49K 0.01% 840
2023
Q3
$29.4K Sell
315
-1,335
-81% -$123K 0.01% 788
2023
Q2
$151K Sell
1,650
-81
-5% -$6.64K 0.04% 306
2023
Q1
$127K Buy
1,731
+147
+9% +$12.7K 0.03% 327
2022
Q4
$132K Buy
1,584
+63
+4% +$5.68K 0.04% 310
2022
Q3
$147K Buy
1,521
+131
+9% +$15.6K 0.05% 257
2022
Q2
$146K Buy
1,390
+148
+12% +$18.9K 0.04% 263
2022
Q1
$214K Buy
1,242
+30
+2% +$4.48K 0.06% 221
2021
Q4
$196K Buy
1,212
+483
+66% +$77.6K 0.05% 241
2021
Q3
$109K Buy
729
+11
+2% +$2.29K 0.03% 306
2021
Q2
$176K Buy
718
+20
+3% +$5.25K 0.05% 224
2021
Q1
$185K Buy
698
+71
+11% +$20K 0.06% 210
2020
Q4
$184K Buy
627
+37
+6% +$9.49K 0.06% 206
2020
Q3
$139K Sell
590
-64
-10% -$14.6K 0.05% 231
2020
Q2
$130K Buy
654
+12
+2% +$2.24K 0.04% 254
2020
Q1
$118K Sell
642
-24
-4% -$4.27K 0.04% 224
2019
Q4
$111K Buy
666
+21
+3% +$3.12K 0.03% 275
2019
Q3
$85K Sell
645
-16
-2% -$2.08K 0.03% 305
2019
Q2
$80K Buy
+661
New +$78.4K 0.03% 306
2019
Q1
Sell
-22
Closed -$3K 1534
2018
Q4
$3K Hold
22
﹤0.01% 968
2018
Q3
$3K Hold
22
﹤0.01% 971
2018
Q2
$2K Hold
22
﹤0.01% 1016
2018
Q1
$1K Buy
22
+5
+29% +$285 ﹤0.01% 1103
2017
Q4
$1K Hold
17
﹤0.01% 1061
2017
Q3
$1K Hold
17
﹤0.01% 1057
2017
Q2
$1K Hold
17
﹤0.01% 1059
2017
Q1
$1K Hold
17
﹤0.01% 1039
2016
Q4
$1K Buy
+17
New +$723 ﹤0.01% 1022

Other funds holding AMED

Parkside Financial Bank & Trust's AMED Position: Q3 2025 in Review

Parkside Financial Bank & Trust sold out of Amedisys (AMED) in Q3 2025, closing a stake of 52 shares — an estimated $5.12K sold.

Parkside Financial Bank & Trust first reported a position in AMED in Q4 2016 and held it in 34 quarters. The position peaked at $214K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Parkside Financial Bank & Trust reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 52 Amedisys shares in Q3 2025, an estimated $5.12K.
  • Parkside Financial Bank & Trust first reported a position in Amedisys in Q4 2016 and held it in 34 quarters.
  • Parkside Financial Bank & Trust's Amedisys position peaked at $214K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q3 2025, filed 30 Oct 2025.